Australia Cardiovascular Devices Market Analysis and Forecasts to 2015

Abstract

Australia Cardiovascular Devices Market Analysis and Forecasts to 2015

Summary

GlobalData’s medical device report: “Australia Cardiovascular Devices Market Analysis and Forecasts to 2015” report provides key data, information and analysis on the Australia cardiovascular devices market. The report provides market landscape, competitive landscape and market trends information on seven market categories including cardiac rhythm management, cardiovascular monitoring and diagnostic devices, cardiovascular prosthetic devices, cardiovascular surgery, interventional cardiology, peripheral vascular devices and electrophysiology. The report provides comprehensive information on the key trends affecting these categories, and key analytical insight on the market dynamics. The report also reviews the competitive landscape in terms of mergers and acquisitions, pipeline products and technology offerings.

Scope

- Forecasts & Analysis of the Australia cardiovascular devices market to 2015.
- Market segmentation by Cardiac Rhythm Management (CRM), Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Interventional Cardiology, Peripheral Vascular Devices and Electrophysiology.
- Market Analysis from 2001 to 2008, including new updated 2008 data.
- Analysis of the leading companies and competitive landscape including 2008 company market share analysis.
- Analysis of key diabetes care pipeline products, new technologies and clinical trials.
- Insight into the key mergers and acquisitions (M&As), partnerships, venture capital and private equity investments.
- Qualitative analysis of market drivers, market limiters regulatory issues and future outlook.

Reasons to buy

- Understand what the new growth opportunities are within the Australia cardiovascular devices market.
- Develop a clear knowledge & understanding of the Australia cardiovascular devices competitor landscape and how this will change to 2015.
- Identify acquisition opportunities across the Australia cardiovascular devices market.
- Identify key winners and losers and who is best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Make more informed business decisions from the insightful and in-depth analysis of the market and the factors shaping it.

Keywords

Australia health structure, drug eluting stent, catheters, tissue valve, mechanical valve, heart valve, cardiac assist, peripheral vascular devices, cardiac rhythm management, pacemakers, implantable defibrillators, average price, market size, competitive analysis, company share, market share, pipeline products, drivers, restraints, volume, Welch Allyn Inc., Terumo Corporation, St. Jude Medical, Inc., Sorin S.p.A., Philips Healthcare, OSI Systems, Inc., Nihon Kohden Corporation, Medtronic, Inc., MAQUET GmbH & Co. KG, GE Healthcare, ev3 Inc., Edwards Lifesciences Corporation, Datascope Corporation, Cordis Corporation, Compumedics Limited, Cardiac Science Corporation, C.R. Bard, Inc., Boston Scientific Corporation, BIOTRONIK GmbH & Co. KG, Biosense Webster, Inc., Arrow International, Inc., ABIOMED, Inc., Abbott Laboratories, AtCor Medical Holdings Limited, Uscom Ltd., HD Medical Group Limited, Sunshine Heart, Inc., Ventracor Limited, CathRx Ltd, BioQ Devices Pty Ltd, Bio Nova International Pty Ltd.